NAMI
GPCR icon

Nomura Asset Management International’s Structure Therapeutics GPCR Stock Holding History

Nomura Asset Management International’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.22M Buy
153,119
+19,104
+14% +$845K 0.01% 794
2026
Q1 		$6.46M Buy
134,015
+51,370
+62% +$3.52M 0.01% 753
2025
Q4 		$5.75M Buy
+82,645
New +$3.37M 0.01% 786

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nomura Asset Management International's GPCR Position: Q2 2026 in Review

Nomura Asset Management International increased its Structure Therapeutics (GPCR) stake by 14% in Q2 2026, buying an estimated $845K and bringing the position to 153,119 shares worth $8.22M. The position accounts for 0.01% of the portfolio, ranked #794.

Nomura Asset Management International first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Nomura Asset Management International held 153,119 shares of Structure Therapeutics worth $8.22M as of Q2 2026.
  • Nomura Asset Management International bought 19,104 Structure Therapeutics shares in Q2 2026, an estimated $845K.
  • Structure Therapeutics made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #794 holding.
  • Nomura Asset Management International first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.